Method of administration of IGF-I

Details Method of administration of IGF-I Method of administration of IGF-I

1995-05-22

1998-04-21

Hill, Jr., Robert J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 4, 514 21, A61K 3800, A61K 3827

Patent

active

057417768

ABSTRACT:
A method is disclosed that comprises administering insulin-like growth factor-I (IGF-I) to a mammal so as to sustain its biological activity in the mammal comprising administering a therapeutically effective amount of IGF-I to the mammal to provide an exposure to IGF-I for a period of time that stimulates the maximum biological response in the mammal, then discontinuing said administration for a period of time equal to or less than the time period used for administration, and repeating this pattern of administration and discontinuance of administration for a period as long as necessary to achieve or maintain the desired biological response in the mammal.

REFERENCES:
patent: 4876242 (1989-10-01), Applebaum
patent: 4988675 (1991-01-01), Froesch et al.
patent: 5068224 (1991-11-01), Fryklund et al.
patent: 5093317 (1992-03-01), Lewis et al.
patent: 5106832 (1992-04-01), Froesch et al.
patent: 5126324 (1992-06-01), Clark et al.
patent: 5187151 (1993-02-01), Clark et al.
patent: 5202119 (1993-04-01), Clark et al.
patent: 5273961 (1993-12-01), Clark
patent: 5374620 (1994-12-01), Clark et al.
patent: 5565428 (1996-10-01), Clark et al.
Baxter, "The somatomedins: insulin-like growth factors" Advances in Clinical Chemistry 25:49-115 (1986).
Binoux, M., "Donnees recentes sur les somatomedines" Annales d'Endocrinologie 41:157-191 (1980).
Chen et al., "Recombinant human IGF-I infusion results in transient improvement in nitrogen balance: evidence for IGF-I autoregulation" US Endocrine Meeting (Abstract 1596) p. 449 (1993).
Clemmons and Van Wyk, "Somatomedin: physiological control and effects on cell proliferation" Handbook Exp. Pharmacol. 57:161-208 (1981).
Cohick and Clemmons, "The insulin-like growth factors" Annu. Rev. Physiol. 55:131-153 (1993).
Duerr et al., "Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure" J. Clin. Invest. 95:619-627 (1995).
Elahi et al., "Hemodynamic and metabolic responses to human insulin-like growth factor I (IGF-I) in men" Modrn Concepts of Insulin-Like Growth Factors, Spenser, ed., New York:Elsevier Science Publ. Co. pp. 219-224 (1991).
Guler et al., "Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects" Proc. Natl. Acad. Sci. USA 86:2868-2872 (Apr. 1989).
Guler et al., "Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man" Acta Endocrinologica 121:101-106 (1989).
Guler et al., "Recombinant human insulin-like growth factor 1 stimulates growth and has distinct effects on organ size in hypophysectomized rats" Proc. Natl. Acad. Sci. USA 85:4889-4893 (1988).
Guler et al., "Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults" New Egland J. of Medicine 317(3):137-140 (1987).
Hammerman, "Ask the expert: What are the clinical uses of IGF I in acute and chronic renal failure?" Ped. Nephrology 8:544 (1994).
Hammerman and Miller, "The growth hormone insulin-like factor axis in kidney revisited" Am. J. Physiol. 265:F1-F14 (1993).
Hammerman and Miller, "Therapeutic use of growth factors in renal failure" J. Am. Soc. Nephrol. 5:1-11 (1994).
Hirschberg et al., "Effects of insulin-like growth factor I on renal function in normal men" Kidney International 43:387-397 (1993).
Hise et al., "Influence of circulating insulin-like growth factor-I compared with that of intrarenal insulin-like growth factor-I on proximal nephron receptor density in rats" Clinical Science 83:233-239 (1992).
Hoogenberg et al., "Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency" Acta Endrocrinologica 129:151-157 (1993).
Ikkos et al., "Glomerular filtration rate and renal plasma flow in acromegaly" Acta Endocrinologica 21:226-236 (1956).
Jabri et al., "Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients" Diabetes 43:369-374 (1994).
Kanety et al., "Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity" Acta Endocrinologica 128:144-149 (1993).
Kerr et al., "Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans" J. Clin. Invest. 91:141-147 (1993).
Kupfer et al., "Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously" J. Clin. Invest. 91:391-396 (1993).
Lieberman et al., "Anabolic effects of recombinant insulin-like growth factor I in AIDS-associated cachexia" US Endocrine Meeting (Abstract 1664) p. 466 (1993).
Lieberman et al., "Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome" J. Clin. Endocrinol. and Metab. 78(2):404-410 (1994).
Lieberman et al., "Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans" J. Clin. Endocrinol. and Metab. 75(1):30-36 (1992).
Miller et al., "Effects of IGF-I on reneal function in end-stage chronic renal failure" Kidney Int. 46:201-207 (1994).
O'Shea and Layish, "Growth hormone and the kidney: a case presentation and review of the literature" J. Am. Soc. Nephrol. 3:157-161 (1992).
O'Shea et al., "Effects of IGF-I on renal function in patients with chronic renal failur" Am. J. Physiol. 264:F917-F922 (1993).
O'Shea et al., "Roles of growth hormone and growth factors in the pathogenesis and treatment of kidney disease" Current Opinion in Neph. and Hypertension 2:67-72 (1993).
Quigley and Baum, "Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport" J. Clin. Invest. 88:368-374 (1991).
Quin et al. New England J. of Medicine 323:1425-1426 (1990).
Rinderknecht and Humbel, "The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin" Journal of Biological Chemistry 253(8):2769-2776 (1978).
Rinderknecht and Humbel, "Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical charaterization, and some biological properties of forms I and II" Proc. Natl. Acad. Sci USA 73(7):2365-2369 (1976).
Schalch et al., "Short-term metabolic effects of recombinant human insulin-like growth factor I (rhIGF-I) in type II diabetes mellitus" Modern Concepts of Insulin-Like Growth Factors, Spencer, ed., New York:Elsevier Science Publ. Co. pp. 705-714 (1991).
Schoenle et al., "Recombinant human insulin-like growth factor I(rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance" Diabetologia 34:675-679 (1991).
Underwood et al., "Regulation of somatomedin-c/insulin-like growth factor I by nutrients" Hormone Res. 24:166-176 (1986).
Usala et al., "Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes" New England J. of Medicine 327(12):853-857 (1992).
Van Wyk et al., "The somatomedins: a family of insulinlike hormones under growth hormone control" Recent Prog. Horm. Res. 30:259-318 (1974).
Walker et al., "Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type)" J. Pediatr. 121:641-646 (1992).
Wilton et al., "Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome)" Acta Paediatr Suppl 383:137-141 (1992).
Zenobi et al., "Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion" J. Clin. Invest. 89:1908-1913 (1992).
Zenobi et al., "Insulin-like growth factor-I improves glucose lipid metabolism in type 2 diabetes mellitus" J. Clin. Invest. 90:2234-2241 (1992).
The Merck Index (Abstract 887), Budavari, et al., Eleventh edition, Rahway, NJ:Merck & Co., Inc

Affiliated with

Also associated with

Rating

Method of administration of IGF-I does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of administration of IGF-I, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of administration of IGF-I will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2057570